Vera Therapeutics (NASDAQ:VERA – Get Free Report) had its price objective raised by research analysts at Wedbush from $21.00 to $34.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Wedbush’s target price would suggest a potential downside of 17.07% from […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has been assigned an average recommendation of “Buy” from the eight analysts that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. […]
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has assigned a strong buy […]
Why Investors and Media are Calling Biotech Showcase™ The Place to Be to Start the Year streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.